Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles

Caitong: YUM CHINA (09987) announces RGM 3.0 strategy, maintains "buy" rating.

Huolong Securities: Construction materials industry "anti-inner tie" breaks traditional track, high-end development opens growth space.

In 2025, the IPO landscape will be fully scanned, with multiple dimensions showing an increasing level of accuracy.
Caitong: YUM CHINA (09987) announces RGM 3.0 strategy, maintains "buy" rating.

Huolong Securities: Construction materials industry "anti-inner tie" breaks traditional track, high-end development opens growth space.

In 2025, the IPO landscape will be fully scanned, with multiple dimensions showing an increasing level of accuracy.

RECOMMEND





